SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
13-Jul-23 5:15 PM View: | Evelo Biosciences, Inc. (EVLO) | 11-Jul-23 | Private Purchase | 5,411,260 | $2.31 | $12,500,000.00 | 215% 2.52M to 7.93M | |
17-Oct-22 4:42 PM View: | Axcella Health Inc. (AXLA) | 13-Oct-22 | Private Purchase | 10,383,800 | $1.64 | $17,029,400.00 | 55% 18.87M to 29.25M | |
01-Jun-22 7:00 PM View: | Evelo Biosciences, Inc. (EVLO) | 27-May-22 | Private Purchase | 27,397,300 | $1.46 | $40,000,000.00 | 119% 23.03M to 50.43M | |
18-Mar-22 8:30 AM View: | Axcella Health Inc. (AXLA) | 16-Mar-22 | Market Purchase | 6,319,370 | $1.91 | $12,070,000.00 | 50% 12.55M to 18.87M | 3% |
23-Mar-21 5:30 PM View: | Rubius Therapeutics, Inc. (RUBY) | 19-Mar-21 | Purchase | 210,000 | $29.00 | $6,090,000.00 | < 1% 38.3M to 38.51M | |
10-Feb-21 5:30 PM View: | Kaleido Biosciences, Inc. (KLDO) | 08-Feb-21 | Market Purchase | 215,000 | $11.50 | $2,472,500.00 | 1% 19.36M to 19.58M | (2%) |
04-Feb-21 5:56 PM View: | Evelo Biosciences, Inc. (EVLO) | 02-Feb-21 | Private Purchase | 130,000 | $15.00 | $1,950,000.00 | < 1% 22.9M to 23.03M | |
25-Nov-20 6:00 PM View: | Seres Therapeutics, Inc. (MCRB) | 23-Nov-20 | Disposition (other) | 7,907,180 | -- | -- | (34%) 22.96M to 15.05M | |
19-Aug-20 8:15 PM View: | Moderna, Inc. (MRNA) | 17-Aug-20 | Disposition (other) | 11,053,000 | -- | -- | (25%) 44.03M to 32.97M | |
01-Jul-20 5:24 PM View: | Evelo Biosciences, Inc. (EVLO) | 29-Jun-20 | Private Purchase | 4,666,670 | $3.75 | $17,500,000.00 | 26% 18.23M to 22.9M | |
08-Jun-20 4:46 PM View: | Kaleido Biosciences, Inc. (KLDO) | 04-Jun-20 | Market Purchase | 2,000,000 | $7.50 | $15,000,000.00 | 12% 17.36M to 19.36M | 24% |
26-May-20 5:00 PM View: | Moderna, Inc. (MRNA) | 22-May-20 | Market Sale | 500,000 | $69.54 | $34,772,200.00 | (1%) 41.76M to 41.26M | (77%) |
26-May-20 5:00 PM View: | Moderna, Inc. (MRNA) | 21-May-20 | Market Sale | 500,000 | $66.89 | $33,447,000.00 | (1%) 42.26M to 41.76M | (84%) |
20-May-20 5:15 PM View: | Axcella Health Inc. (AXLA) | 18-May-20 | Purchase | 3,800,000 | $4.75 | $18,050,000.00 | 43% 8.75M to 12.55M | |
13-May-20 6:12 PM View: | Moderna, Inc. (MRNA) | 11-May-20 | Disposition (other) | 12,281,200 | -- | -- | (23%) 54.54M to 42.26M | |
11-Dec-19 7:38 PM View: | Moderna, Inc. (MRNA) | 11-Dec-19 | Market Sale | 238,301 | $18.65 | $4,445,460.00 | (< 1%) 51.71M to 51.47M | (562%) |
11-Dec-19 7:38 PM View: | Moderna, Inc. (MRNA) | 10-Dec-19 | Market Sale | 25,417 | $18.96 | $481,871.00 | (< 1%) 51.73M to 51.71M | (551%) |
11-Dec-19 7:38 PM View: | Moderna, Inc. (MRNA) | 09-Dec-19 | Disposition (other) | 9,235,720 | -- | -- | (15%) 61.14M to 51.91M | |
11-Dec-19 7:38 PM View: | Moderna, Inc. (MRNA) | 09-Dec-19 | Market Sale | 172,137 | $18.99 | $3,269,610.00 | (< 1%) 51.91M to 51.73M | (550%) |
31-Oct-19 7:00 PM View: | Transmedics Group, Inc. (TMDX) | 29-Oct-19 | Disposition (other) | 2,840,190 | -- | -- | (96%) 2.96M to 120.59K | |
15-May-19 4:18 PM View: | Axcella Health Inc. (AXLA) | 13-May-19 | Conversion | 5,533,970 | -- | -- | 163% 3.39M to 8.93M | |
15-May-19 4:18 PM View: | Axcella Health Inc. (AXLA) | 13-May-19 | Purchase | 500,000 | $20.00 | $10,000,000.00 | 6% 8.93M to 9.43M | |
06-May-19 6:47 PM View: | Transmedics Group, Inc. (TMDX) | 06-May-19 | Conversion | 2,047,250 | -- | -- | 121% 1.69M to 3.74M | |
06-May-19 6:47 PM View: | Transmedics Group, Inc. (TMDX) | 06-May-19 | Acquisition (other) | 483,021 | -- | -- | 13% 3.74M to 4.22M | |
06-May-19 6:47 PM View: | Transmedics Group, Inc. (TMDX) | 06-May-19 | Disposition (other) | 1,690,580 | -- | -- | (40%) 4.22M to 2.53M | |
06-Mar-19 4:43 PM View: | Kaleido Biosciences, Inc. (KLDO) | 04-Mar-19 | Conversion | 1,120,700 | -- | -- | 63% 1.78M to 2.9M | |
23-Jul-18 4:34 PM View: | Rubius Therapeutics, Inc. (RUBY) | 20-Jul-18 | Conversion | 33,296,500 | -- | -- | 666% 5.0M to 38.3M | |
15-May-18 8:43 PM View: | Evelo Biosciences, Inc. (EVLO) | 11-May-18 | Conversion Duplicate | 14,622,100 | -- | -- | 439% 3.33M to 17.95M | |
15-May-18 8:43 PM View: | Evelo Biosciences, Inc. (EVLO) | 11-May-18 | Purchase Duplicate | 281,250 | $16.00 | $4,500,000.00 | 2% 17.95M to 18.23M |